Clinical Trial Update: Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sirolimus-eluting stents for chronic total occlusions in the coronary arteries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis
• Total Occlusion of the Coronary Arteries

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: R&D Cardiologie | Conditions: Coronary Artery Disease, Coronary Disease | Phase 3 | Status: COMPLETED